Supplementary Figure S4 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies

Ekta Patel,Natalia V. Malkova,David Crowe,Magali Pederzoli-Ribeil, Damiano Fantini,Manoussa Fanny,Hanumantha Rao Madala,Kurt A. Jenkins,Oleg Yerov, Justin Greene,Wilson Guzman, Caitlin O'Toole,Jacob Taylor, Rebekah K. O'Donnell,Parker Johnson, Bernard B. Lanter, Brian Ames, Jia Chen,Sallyann Vu, Hsin-Jung Wu, Susan Cantin,Megan McLaughlin, Yu-Shan S. Hsiao, Dheeraj S. Tomar,Raphael Rozenfeld, Lakshmanan Thiruneelakantapillai, Ronan C. O'Hagan,Benjamin Nicholson, Jennifer O'Neil,Carl Uli Bialucha

crossref(2024)

引用 0|浏览1
暂无评分
摘要

Supplemental Figure S4: Gating strategy for multi-color flow cytometry analysis of tumor-infiltrating and splenic immune cell populations.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要